Skip to Content

Clodronic Acid

In some countries, this medicine may only be approved for veterinary use.



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Bone resorption inhibitor

Treatment of hypercalcemia

Adjunct to antineoplastic therapy

Chemical Name

Phosphonic acid, (dichlorometylene)bis-

Foreign Names

  • Acidum Clodronicum (Latin)
  • Clodronsäure (German)
  • Acide clodronique (French)
  • Acido clodronico (Spanish)

Generic Names

Brand Names

  • Bonefos
    Er-Kim, Turkey; Schering Oy, Tunisia
  • Clasteon
    Beacon Pharmaceuticals, Cyprus
  • Cledos
    West Pharma, Tunisia
  • Clodron (Clodronic Acid and Lidocaine)
    Fidia Farmaceutici, Italy
  • Niklod (Clodronic Acid and Lidocaine)
    Caber, Italy
  • Osphos (veterinary use)
    Dechra, Ireland; Dechra, United States
  • Ostac
    Roche, Oman
  • Acido Clodronico EG
    EG, Italy
  • Acido Clodronico Sandoz
    Sandoz, Italy
  • Actabone
    Actavis, Indonesia
  • Bonefos
    Bayer, Bosnia & Herzegowina; Bayer, Belgium; Bayer, Canada; Bayer, China; Bayer, Denmark; Bayer, Spain; Bayer, United Kingdom; Bayer, Hong Kong; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Lithuania; Bayer, Latvia; Bayer, Malta; Bayer, Netherlands; Bayer, Philippines; Bayer, Poland; Bayer, Serbia; Bayer, Sweden; Bayer, Slovakia; Bayer AB, Norway; Bayer Austria, Austria; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer Oy, Macedonia; Bayer Pharma, Israel; Bayer Schering, Australia; Bayer Schering, Czech Republic; Bayer Schering, Taiwan; Bayer Vital, Germany; Bayer-Schering, Romania; Euro Registratie, Netherlands; Leiras, Oman; Medcor, Netherlands; Schering, Brazil; Schering, Pakistan; Scherring, Egypt
  • Bonephos
    Bayer Schering, South Africa
  • Clasteon
    Abiogen Pharma, Italy; Beacon, Malta; Beacon Pharmaceuticals, United Kingdom; Sunovion Pharmaceuticals, Canada
  • Clastoban
    Bioprojet, France
  • Climaclod
    Mastelli, Italy
  • Clobir
    Actavis Group, Russian Federation
  • Clodeosten
    SF Group, Italy
  • Clodron - 1 A Pharma
    1 A Pharma, Germany
  • Clodron beta
    Betapharm, Germany
  • Clodron HEXAL
    Hexal, Germany
  • Clodronato ABC
    ABC Farmaceutici, Italy
  • Clodronato Teva
    Teva Italia, Italy
  • Clody
    Promedica, Italy
  • De Wei
    Baiyunshan, China
  • Di Gai Na
    Sanjing Pharmaceutical Co., Ltd, China
  • Difosfonal
    SPA, Italy
  • Lodronat
    Boehringer Ingelheim, Lithuania; Riemser, Czech Republic; Riemser Pharma, Austria
  • Loron
    Intrapharm Laboratories, United Kingdom
  • Moticlod
    Lisapharma, Vietnam; SF Group, Italy
  • Niklod
    Savio I.B.N., Italy
  • Ostac
    Riemser, Netherlands; Riemser Pharma, Germany; Roche, Portugal
  • Osteonorm
    Caber, Italy
  • Sinclote
    Sinphar, Taiwan
  • Sindronat
    Actavis, Bulgaria; Actavis, Romania; Actavis Group, Poland; Sindan, Slovakia
  • Traxovical
    Athena Pharma Italia, Italy
  • Ya Kun Yu
    Lingkang Pharmaceutical, China


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.